Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)
-NSE 966.15 
2.70(0.28%) May 17
| Prev Close: | 968.85 |
|---|
| Open: | 970.10 |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 958.00 - 976.60 |
|---|
| 52wk Range: | 553.00 - 998.85 |
|---|
| Volume: | 414,812 |
|---|
| Avg Vol (3m): | 872,900 |
|---|
| Market Cap: | 1.00T |
|---|
| P/E (ttm): | 35.55 |
|---|
| EPS (ttm): | 27.18 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in INR.
Headlines
- INDIA-PRESS-India to regulate prices of 652 drugs - Economic Timesat Reuters(Thu, May 16)
- Indian shares gain for fourth day as rate-cut hopes continue to aidat Reuters(Thu, Apr 25)
- Indian shares gain more than 1 pct, ending 5-day losing streakat Reuters(Wed, Apr 10)
- Indian shares gain for 4th day; Reliance, Sun Pharma leadat Reuters(Tue, Apr 2)
- U.S. high court weighs generic drugmaker liabilityat Reuters(Tue, Mar 19)
- Top court to hear arguments over generic drugmaker liabilityat Reuters(Mon, Mar 18)
- UPDATE 1-India's Ranbaxy surprises with Q4 loss, sees modest sales growth in 2013at Reuters(Tue, Feb 26)
- Sun Pharma and Taro Announce Termination of Proposed TransactionBusiness Wire(Fri, Feb 8)
- Taro Postpones Shareholders Meetings on Proposed Merger With Sun PharmaBusiness Wire(Wed, Nov 14)
- Ericsson and DUSA Pharmaceuticals Among Most Active Stocks in Nasdaq Pre-Marketat Minyanville(Thu, Nov 8)
Reports
- No Reports available for SUNPHARMA.NS at this time.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 9.56 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Sun Pharmaceutical Industries Limited, a specialty pharma company, manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally.
View More